Fixeddose combination of rosuvastatin + ezetimibe: ease of use, safety and efficacy

Por I. A. Alekseeva, T. E. Kolmakova, M. B. Ezhov
Publicado em 2019-10-01

Atorvastatin: old friend in the light of novel coronavirus infection’s pandemia

Por M. V. Ezhov, T. E. Kolmakova, M. M. Matveeva, I. A. Alekseeva
Publicado em 2022-04-01

Efficiency of high-intensity therapy with rosuvastatin for secondary prevention of cardiovascular complications in patients with a very high risk

Por T. E. Kolmakova, I. A. Alekseeva, N. A. Tmoyan, M. V. Ezhov
Publicado em 2022-01-01

Preclinical markers of carotid atherosclerosis and cardiovascular risk assessed by the ESH/ESC scale (2003, 2007, 2009)

Por S. Sh. Urazalina, A. N. Rogoza, T. V. Balakhonova, R. P. Myasnikov, T. E. Kolmakova, Yu. A. Karpov, V. V. Kukharchuk, S. A. Boytsov
Publicado em 2011-08-01

Trends in hospitalizations of patients with acute coronary syndrome and indicators of the atmospheric state in Moscow in 2009-2012

Por I L Kozlovskaia, O S Bulkina, V V Lopukhova, T E Kolmakova, Iu A Karpov, I V Starostin, V L Baratashvili, K G Rubinshteĭn, S V Emelina, V P Borovikov
Publicado em 2014-12-01